LJLennert Janssen

Lennert Janssen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lennert Janssen has a total of 187 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Salmonella exploits USP32 to coordinate Rab14 and Rab11 recycling pathways for intracellular survival

    by Aysegul Sapmaz, Sabina Y van der Zanden, Jimmy J.L.L Akkermans, Loreline Menager, Lennert Janssen, Esteban Francois, Natascha Hagoort, Ilana Berlin, Jacques Neefjes, Virginie Stevenin

    Many intracellular bacterial pathogens establish membrane-bound niches derived from host material to survive and replicate within host cells. These compartments are carved through subversion of host intracellular trafficking pathways to modulate the composition of the vacuolar membrane. Although recycling-associated small Rab GTPases are frequently observed at infection sites, their role in membrane remodeling and cargo sorting has remained poorly understood. Here, we leverage the extensive early membrane remodeling occurring during Salmonella infection to dissect this process. Using endogenously tagged cell lines, we characterize the dynamics of the recycling small GTPases Rab14 and Rab11 at Salmonella intracellular infection sites. We report that Rab14 recruits its effector Rufy1, which mediates sorting of CI-M6PR through recycling tubules. Subsequently, Rab11 disperses the newly formed recycling endosomes by interacting with its effector Fip3 for retrograde transport. This pathway is controlled by the deubiquitinating enzyme USP32, which targets both Rab14 and Rab11, enhancing their interactions with Rufy1 and Fip3, respectively. We further show that USP32 is recruited to the infection site via local enrichment of phosphatidylserine-positive membranes, a process triggered by the Salmonella effector proteins SopE/E2. Importantly, silencing USP32 significantly impairs intracellular bacterial survival. Our findings reveal a remarkable exploitation of host signaling and trafficking pathways by Salmonella to construct a pro-replicative niche. Targeting these pathways may offer new strategies for therapeutic intervention against intracellular bacterial infections.


  • Open Access

    Dual-colour super-resolution cryoCLEM in mammalian cells using the fluorescent proteins rsTagRFP and rsEGFP2

    by Mart G.F. Last, Maartje van Klaveren, Lennert Janssen, Nickels Jensen, Isabelle Jansen, Stefan Jakobs, Lenard M. Voortman, Thomas H. Sharp


  • Open Access

    Colon cancer and cell transformation by clinical Salmonella strains are associated with bacterial virulence and intracellular fitness

    by Virginie Stévenin, Claudia E. Coipan, Janneke W. Duijster, Daphne M. van Elsland, Linda Voogd, Angela H.A.M. van Hoek, Lucas M. Wijnands, Lennert Jansen, Jimmy J.L.L. Akkermans, Andra Neefjes-Borst, et al.

    SUMMARY: Non-typhoidal Salmonella (NTS) are facultative intracellular pathogens that are associated epidemiologically and experimentally with colon cancer development. Yet, the driving factors of Salmonella -induced cell transformation are mostly unknown. We compared 30 (case) NTS clinical strains isolated from patients who were diagnosed with colon cancer >1 year after NTS infection, versus 30 (control) strains from patients who did not develop colon cancer. While we observed diverse cell invasion and transformation efficiencies among the 60 NTS strains, case strains showed higher transformation efficiency than matching control strains. Genomic and transcriptomic analyses showed that transformation efficiency could not be attributed to specific genomic features, but was associated with gene expression, particularly metabolic genes and regulons. Moreover, high-transforming NTS strains display increased capacity to utilize various nutrient sources, including carbohydrates and amino acids, and grow significantly faster intracellularly than low-transforming NTS. Our results link NTS intracellular virulence to cancer promotion. Graphical In brief: Non-typhoidal Salmonella (NTS) infections can promote cell transformation and colon cancer progression. Yet, little is known about the driving factors of Salmonella -induced transformation. Stévenin et al. performed a multi-omic characterization of clinical NTS strains identified in a nation-wide epidemiological study as associated with colon cancer and revealed a link between bacterial virulence, intracellular fitness, and host cell transformation. Highlights: - Cancer-associated clinical NTS generate more cell transformation than matching control NTS. - NTS transformation efficiency did not correlate with specific genetic features. - NTS transformation efficiency correlates with gene expression and bacterial metabolic needs. - High-transforming NTS display increased virulence and intracellular fitness.

  • Open Access

    The SPPL3-defined glycosphingolipid repertoire regulates immune responses by improving HLA class I access

    by Marlieke L.M. Jongsma, Matthijs Raaben, Antonius A. de Waard, Tao Zhang, Birol Cabukusta, René Platzer, Vincent A. Blomen, Anastasia Xagara, Tamara Verkerk, Sophie Bliss, et al.

    Summary: HLA class I (HLA-I) drives immune responses by presenting antigen-derived peptides to cognate CD8 + T cells. This process is often hijacked by tumors and pathogens for immune evasion. Since therapeutic options for restoring HLA-I antigen presentation are limited, we aimed to identify new HLA-I pathway targets. By iterative genome-wide screens we uncovered that the cell surface glycosphingolipid (GSL) repertoire determines effective HLA-I antigen presentation. We show that absence of the protease SPPL3 augments B3GNT5 enzyme activity, resulting in upregulated levels of surface (neo)lacto-series GSLs. These GSLs sterically impede molecular interactions with HLA-I and diminish CD8 + T cell activation. In accordance, a disturbed SPPL3-B3GNT5 pathway in glioma associates with decreased patient survival. Importantly, we show that this immunomodulatory effect can be reversed through GSL synthesis inhibition using clinically approved drugs. Overall, our study identifies a GSL signature that functionally inhibits antigen presentation and represents a potential therapeutic target in cancer, infection and autoimmunity.


  • Invariant chain regulates endosomal fusion and maturation through an interaction with the SNARE Vti1b

    by Azzurra Margiotta, Dominik Frei, Ingrid Hegnes Sendstad, Lennert Janssen, Jacques Neefjes, Oddmund Bakke

    The Invariant chain (Ii, CD74) is a multifunctional regulator of adaptive immune responses and responsible for sorting MHC-I, MHC-II and other Ii-associated molecules to a specific endosomal pathway. When Ii is expressed, endosomal maturation and proteolytic degradation of proteins are delayed and in non-antigen presenting cells the endosomal size increase, but he molecular mechanisms are not known. We identified that a SNARE, Vti1b, is essential for regulating these Ii induced effects. Vti1b binds to Ii and Vti1b is localized at the contact sites of fusing Ii positive endosomes. Furthermore, a tailless Ii that is not internalized from the plasma membrane relocates Vti1b to the plasma membrane. KO of Ii in an antigen presenting cell line was found to speed up endosomal maturation and silencing of Vti1b inhibits the Ii induced maturation delay. Our results suggest that Ii, by interacting with the SNARE Vti1b in antigen presenting cells, direct specific Ii associated SNARE mediated fusion in the early part of the endosomal pathway that lead to a slower endosomal maturation for efficient antigen processing and MHC antigen loading.


  • Homeostasis of soluble proteins and the proteasome post nuclear envelope reformation in mitosis

    by Menno Spits, Lennert J. Janssen, Lenard M. Voortman, Raymond Kooij, Anna C. M. Neefjes, Huib Ovaa, Jacques Neefjes

    Upon nuclear envelope (NE) fragmentation in the prometaphase, the nuclear and cytosolic proteomes mix and must be redefined to reinstate homeostasis. Here, by using a molecular GFP ladder, we show that in early mitosis, condensed chromatin excludes cytosolic proteins. When the NE reforms tightly around condensed chromatin in late mitosis, large GFP multimers are automatically excluded from the nucleus. This can be circumvented by limiting DNA condensation with Q15, a condensin II inhibitor. Soluble small and other nuclear localization sequence (NLS)-targeted proteins then swiftly enter the expanding nuclear space. We then examined proteasomes, which are located in the cytoplasm and nucleus. A significant fraction of 20S proteasomes is imported by the importin IPO5 within 20 min of reformation of the nucleus, after which import comes to an abrupt halt. This suggests that maintaining the nuclear–cytosol distribution after mitosis requires chromatin condensation to exclude cytosolic material from the nuclear space, and specialized machineries for nuclear import of large protein complexes, such as the proteasome.


  • Open Access

    Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway

    by Ruud H. Wijdeven, Hans Janssen, Leila Nahidiazar, Lennert Janssen, Kees Jalink, Ilana Berlin, Jacques Neefjes

    Autophagy is the main homeostatic pathway guiding cytosolic materials for degradation by the lysosome. Maturation of autophagosomes requires their transport towards the perinuclear region of the cell, with key factors underlying both processes still poorly understood. Here we show that transport and positioning of late autophagosomes depends on cholesterol by way of the cholesterol-sensing Rab7 effector ORP1L. ORP1L localizes to late autophagosomes and—under low-cholesterol conditions—contacts the ER protein VAP-A, forming ER-autophagosome contact sites, which prevent minus-end transport by the Rab7–RILP–dynein complex. ORP1L-mediated contact sites also inhibit localization of PLEKHM1 to Rab7. PLEKHM1, together with RILP, then recruits the homotypic fusion and vacuole protein-sorting (HOPS) complex for fusion of autophagosomes with late endosomes and lysosomes. Thus, ORP1L, via its liganding by lipids and the formation of contacts between autophagic vacuoles and the ER, governs the last steps in autophagy that lead to the lysosomal degradation of cytosolic material.


  • Open Access

    An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport

    by Marlieke L.M. Jongsma, Ilana Berlin, Ruud H.M. Wijdeven, Lennert Janssen, George M.C. Janssen, Malgorzata A. Garstka, Hans Janssen, Mark Mensink, Peter A. van Veelen, Robbert M. Spaapen, et al.


  • Open Access

    Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity

    by Rik van der Kant, Caspar T.H. Jonker, Ruud H. Wijdeven, Jeroen Bakker, Lennert Janssen, Judith Klumperman, Jacques Neefjes


  • Open Access

    Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules

    by Celia R. Berkers, Annemieke de Jong, Karianne G. Schuurman, Carsten Linnemann, Hugo D. Meiring, Lennert Janssen, Jacques J. Neefjes, Ton N. M. Schumacher, Boris Rodenko, Huib Ovaa

    Peptide splicing, in which two distant parts of a protein are excised and then ligated to form a novel peptide, can generate unique MHC class I–restricted responses. Because these peptides are not genetically encoded and the rules behind proteasomal splicing are unknown, it is difficult to predict these spliced Ags. In the current study, small libraries of short peptides were used to identify amino acid sequences that affect the efficiency of this transpeptidation process. We observed that splicing does not occur at random, neither in terms of the amino acid sequences nor through random splicing of peptides from different sources. In contrast, splicing followed distinct rules that we deduced and validated both in vitro and in cells. Peptide ligation was quantified using a model peptide and demonstrated to occur with up to 30% ligation efficiency in vitro, provided that optimal structural requirements for ligation were met by both ligating partners. In addition, many splicing products could be formed from a single protein. Our splicing rules will facilitate prediction and detection of new spliced Ags to expand the peptidome presented by MHC class I Ags.